Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

KURA ONCOLOGY, INC.

(KURA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société KURA ONCOLOGY, INC.
09:07aKura Oncology Receives FDA Authorization to Proceed with Phase 1b Study of KO-539 in Ac..
AQ
01/20KURA ONCOLOGY, INC. : Other Events (form 8-K)
AQ
01/20Kura Oncology Receives FDA Authorization to Proceed with Phase 1b Study of KO-539 in Ac..
AQ
2021Kura Oncology Doses First Patient in Phase 1/2 Clinical Trial of Tipifarnib in Combinat..
GL
2021SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kura ..
PR
2021Kura Oncology Reports Final Results from Phase 2 Study of Tipifarnib in T-Cell Lymphoma
AQ
2021Kura Oncology Reports Preclinical Data Highlighting Synergistic Activity of Menin Inhib..
GL
2021KURA ONCOLOGY, INC. : Other Events (form 8-K)
AQ
2021Kura Oncology Provides Update on Phase 1b Study of KO-539 in Acute Myeloid Leukemia
AQ
2021Kura Oncology to Participate in Two Upcoming Investor Conferences
GL
2021KURA ONCOLOGY : Q3 Earnings Snapshot
AQ
2021Kura Oncology Reports Third Quarter 2021 Financial Results - Form 8-K
PU
2021Kura Oncology - Corporate Presentation - November 2021
PU
2021KURA ONCOLOGY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
2021Kura Oncology Reports Third Quarter 2021 Financial Results
AQ
2021Kura Oncology to Participate in Credit Suisse Healthcare Conference
GL
2021Kura Oncology to Report Third Quarter 2021 Financial Results
GL
2021KURA ONCOLOGY : Appoints Teresa Bair as Chief Legal Officer
AQ
2021KURA ONCOLOGY : Appoints Teresa Bair as Chief Legal Officer
GL
2021KURA ONCOLOGY : Corporate Presentation - September 2021
PU
2021KURA ONCOLOGY : to Participate in Two Upcoming Investor Conferences
AQ
2021KURA ONCOLOGY : Q2 Earnings Snapshot
AQ
2021KURA ONCOLOGY : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF..
AQ
2021KURA ONCOLOGY : Reports Second Quarter 2021 Financial Results
AQ
2021KURA ONCOLOGY : to Participate in Wedbush PacGrow Healthcare Virtual Conference
AQ
2021Kura Oncology to Report Second Quarter 2021 Financial Results
GL
2021KURA ONCOLOGY, INC. : Change in Directors or Principal Officers, Financial Statements and ..
AQ
2021Kura Oncology Appoints Helen Collins, M.D. to Board of Directors
GL
2021Kura Oncology Announces Clinical Collaboration to Evaluate Tipifarnib in Combination wi..
GL
2021KURA ONCOLOGY, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
2021Kura Oncology Doses First Patient in Phase 1b Expansion Cohorts with Menin Inhibitor KO..
GL
2021Kura Oncology to Participate in JMP Securities Life Sciences Conference
GL
2021KURA ONCOLOGY : Appoints Carol Schafer to Board of Directors (Form 8-K)
PU
2021KURA ONCOLOGY, INC. : Change in Directors or Principal Officers, Financial Statements and ..
AQ
2021Kura Oncology Appoints Carol Schafer to Board of Directors
GL
2021KURA ONCOLOGY, INC. : Termination of a Material Definitive Agreement (form 8-K)
AQ
2021KURA ONCOLOGY, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Fin..
AQ
2021Kura Oncology to Participate in Cowen Virtual Oncology Innovation Summit
GL
2021KURA ONCOLOGY : Q1 Earnings Snapshot
AQ
2021KURA ONCOLOGY : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF..
AQ
2021KURA ONCOLOGY : Corporate Presentation - May 2021
PU
2021Kura Oncology Reports First Quarter 2021 Financial Results
GL
2021KURA ONCOLOGY : to Report First Quarter 2021 Financial Results
AQ
2021Kura Oncology Announces Publication of Tipifarnib Phase 2 Data in Journal of Clinical O..
GL
2021KURA ONCOLOGY : Corporate Presentation - March 2021
PU
2021KURA ONCOLOGY : Corporate Presentation - February 2021
PU
2021KURA ONCOLOGY : 4Q Earnings Snapshot
AQ
2021KURA ONCOLOGY : Management's Discussion and Analysis of Financial Condition and Results of..
AQ
2021Kura Oncology Reports Fourth Quarter and Full Year 2020 Financial Results
GL
2021Kura Oncology Receives FDA Breakthrough Therapy Designation for Tipifarnib in Head and ..
GL
2021Kura Oncology to Participate in Four Upcoming Investor Conferences
GL
2021KURA ONCOLOGY : to Report Fourth Quarter and Full Year 2020 Financial Results
AQ
2021KURA ONCOLOGY : An amendment to the SC 13G filing
PU
2021KURA ONCOLOGY, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
2021Kura Oncology to Participate in H.C. Wainwright BioConnect 2021 Conference
GL
2021Kura Oncology to Present at J.P. Morgan Healthcare Conference
GL
2020KURA ONCOLOGY : Announces Closing of Public Offering and Full Exercise of Option to Purcha..
AQ
2020Kura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purch..
GL
2020Kura Oncology to Participate in the JMP Securities Hematology Summit
GL
2020KURA ONCOLOGY : Form of prospectus disclosing information, facts, events covered in both f..
PU
2020KURA ONCOLOGY, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020Kura Oncology Announces Pricing of $300 Million Public Offering of Common Stock
GL
2020KURA ONCOLOGY : Form of prospectus disclosing information, facts, events covered in both f..
PU
2020KURA ONCOLOGY : S-3asr
PU
2020Kura Oncology Announces Commencement of Public Offering of Common Stock
GL
2020KURA ONCOLOGY : Thinking about buying stock in Affimed NV, Kura Oncology, Matinas BioPharm..
PR
2020KURA ONCOLOGY, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020KURA ONCOLOGY : Corporate Presentation - December 2020
PU
2020KURA ONCOLOGY : Investor Event Presentation
PU
2020Kura Oncology Presents First Clinical Data for Menin Inhibitor KO-539 at American Socie..
GL
2020KURA ONCOLOGY : to Host Virtual Investor Event on December 5, 2020
AQ
2020KURA ONCOLOGY : to Host Virtual Investor Event on December 5, 2020
AQ
2020Kura Oncology to Host Virtual Investor Event on December 5, 2020
GL
2020KURA ONCOLOGY : Corporate Presentation - November 2020
PU
2020KURA ONCOLOGY : 3Q Earnings Snapshot
AQ
1  2  3  4Next
Upcoming event on KURA ONCOLOGY, INC.